Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page
- Check3 days agoChange DetectedA site-wide NIH notice was added announcing updates and FAQs about terminology changes during the agency transition.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision number was updated from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe site revision label in the page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check38 days agoChange DetectedRevision: v3.7.0 was added to the page, signaling a new revision of the study record. This update appears to be a maintenance/version update rather than a change to study details or results.SummaryDifference19%

- Check59 days agoChange DetectedThe page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a minor metadata update to the study record.SummaryDifference0.1%

- Check66 days agoChange DetectedThe study record’s update log was modified to add August 2026 entries and October/December 2026 entries while removing earlier dates, indicating administrative maintenance of the record rather than substantive content changes.SummaryDifference0.3%

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.